ISEC Healthcare Ltd.

Catalist:40T Stock Report

Market Cap: S$221.4m

ISEC Healthcare Past Earnings Performance

Past criteria checks 2/6

ISEC Healthcare has been growing earnings at an average annual rate of 17.9%, while the Healthcare industry saw earnings growing at 15.1% annually. Revenues have been growing at an average rate of 14.6% per year. ISEC Healthcare's return on equity is 15.2%, and it has net margins of 18.2%.

Key information

17.9%

Earnings growth rate

13.1%

EPS growth rate

Healthcare Industry Growth9.7%
Revenue growth rate14.6%
Return on equity15.2%
Net Margin18.2%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How ISEC Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

Catalist:40T Revenue, expenses and earnings (SGD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 247013120
31 Dec 237013120
30 Sep 237013120
30 Jun 236913120
31 Mar 236814110
31 Dec 226313100
30 Sep 225912100
30 Jun 2249990
31 Mar 2243890
31 Dec 2140790
30 Sep 2137680
30 Jun 2140780
31 Mar 2136580
31 Dec 2036580
30 Sep 2038690
30 Jun 2037590
31 Mar 2042790
31 Dec 1943790
30 Sep 1942780
30 Jun 1941780
31 Mar 1941980
31 Dec 1840880
30 Sep 1839880
30 Jun 1839980
31 Mar 1838880
31 Dec 1737870
30 Sep 1736770
30 Jun 1733770
31 Mar 1732770
31 Dec 1631670
30 Sep 1629570
30 Jun 1628470
31 Mar 1627470
31 Dec 1527370
30 Sep 1527280
30 Jun 1526280
31 Mar 1524270
31 Dec 1422260
30 Sep 1419340
31 Mar 1418330
31 Dec 1318330

Quality Earnings: 40T has high quality earnings.

Growing Profit Margin: 40T's current net profit margins (18.2%) are lower than last year (19.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 40T's earnings have grown by 17.9% per year over the past 5 years.

Accelerating Growth: 40T's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 40T had negative earnings growth (-5.9%) over the past year, making it difficult to compare to the Healthcare industry average (-2%).


Return on Equity

High ROE: 40T's Return on Equity (15.2%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.